Immunotherapy advances in head and neck cancer care: implications for prescribers

Key Points

• The research aims to explore the impact of pembrolizumab on treating locally advanced head and neck cancer through immunotherapy.
• Discusses immunotherapy approaches for head and neck cancer
• Highlights the role of pembrolizumab
• Examines the need for coordinated care among prescribers
• Pembrolizumab shows promise in improving treatment outcomes
• Highlights the importance of a patient-centred management approach
• Suggests that prescribers must adapt to new treatment protocols